Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Valiant organicsNSE:VALIANTORG +4.99%74 EV-to-EBIT is 16.03 as of Sep. 15, 2026, which is 11% below its 10-year median of 18.02. GuruFocus rates NSE:VALIANTORG with a GF Score™ of 74/100 and a GF Value™ of ₹367.60 (Fairly Valued). The stock has 7 warning signs investors should review. Among 1,284 Chemicals companies, Valiant organics ranks better than 50.78% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Valiant organics's Enterprise Value for the quarter that ended in Jun. 2026 was ₹7,684 Mil.
Valiant organics's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹848 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Valiant organics EV-to-EBIT Related Terms
Valiant organics EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Valiant organics's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Valiant organics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Valiant organics EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Valiant organics's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Valiant organics's EV-to-EBIT falls into.
Valiant organics's current Enterprise Value is ₹13,598 Mil.
Valiant organics's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹848 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Valiant organics (NSE:VALIANTORG) has a EV-to-EBIT of 16.03 as of Sep. 15, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Valiant organics and its competitors. This is 11% below median its historical median of 18.02. According to the industry distribution chart, Valiant organics ranks #632 out of 1284 companies in the Chemicals industry, placing it in the top 49.2%.
Is Valiant organics' EV-to-EBIT too high?
Valiant organics' current EV-to-EBIT of 16.03 is 11% below median its 10-year median of 18.02. The Chemicals industry median EV-to-EBIT is 16.31. Valiant organics' value of 16.03 is 1.7% below this industry median. Based on the distribution chart, Valiant organics ranks #632 out of 1284 companies in the Chemicals industry, which is above the industry midpoint. Overall, Valiant organics has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Valiant organics' EV-to-EBIT compare to DOW?
According to the Chemicals industry distribution chart, Valiant organics ranks #632 out of 1284 companies for EV-to-EBIT. This puts Valiant organics in the upper half of its industry. The industry median EV-to-EBIT is 16.31. Valiant organics' value of 16.03 is 1.7% below this benchmark. While the company's 10-year median is 18.02 vs. the industry median of 16.31, Valiant organics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 16.31, based on 1,284 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Valiant organics's current EV-to-EBIT of 16.03 is 1.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Valiant organics and its competitors. For the Chemicals industry, the median EV-to-EBIT is 16.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Valiant organics's current EV-to-EBIT is 16.03, which is 11% below median its own 10-year median of 18.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valiant organics stock overvalued right now?
Based on GuruFocus' analysis, Valiant organics (NSE:VALIANTORG) is currently considered Fairly Valued. The stock's GF Value™ is ₹367.60, compared to a current price of ₹396.30 — trading 7.8% above its estimated fair value. The current EV-to-EBIT is 16.03, which is 11% below median its 10-year median of 18.02 and 1.7% below the Chemicals industry median of 16.31. Valiant organics' overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Valiant organics (NSE:VALIANTORG), the current EV-to-EBIT is 16.03 as of Sep. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Valiant organics (NSE:VALIANTORG) Overvalued in 2026?
Based on GuruFocus' analysis, Valiant organics stock appears to be overvalued.
The current stock price of ₹396.30 is trading 7.8% above its estimated GF Value™ of ₹367.60.
GuruFocus considers Valiant organics to be Fairly Valued.
Key valuation signals for NSE:VALIANTORG:
EV-to-EBIT: 16.03 (11% below median its 10-year median of 18.02)
GF Value™: ₹367.60 vs. price of ₹396.30 (7.8% above fair value)
Industry Position: 1.7% below the Chemicals median (#632 of 1284)
No single metric tells the full story. See the NSE:VALIANTORG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Valiant organics Ltd engages in the production and marketing of a diverse range of specialty chemicals and pharmaceutical intermediates. It is a manufacturer of compounds such as chlorophenol derivatives, benzene derivatives, Para Nitro Aniline (PNA), Para Amino Phenol (PAP), Ortho Anisidine, and Para Anisidine. The company's product portfolio serves a broad spectrum of industries, including agrochemicals, pharmaceuticals, dyes, pigments, cosmetics, rubber, polymers, and veterinary drugs. These chemicals are produced through sophisticated process chemistries, including chlorination, Ammonolysis, Hydrogenation, Acetylation, Sulphonation, and Methoxylation, ensuring a wide array of high-quality offerings. It operates in a single segment, Chemicals, with operations in India and outside India.
74GF Score
Get the complete analysis for NSE:VALIANTORG
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VALIANTORG has been successfully added to your 
